Assessment of electrical dyssynchrony in cardiac resynchronization therapy: 12-lead electrocardiogram vs. 96-lead body surface map
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
Grantová podpora
Ministry of Health of the Czech Republic
PubMed
36107025
PubMed Central
PMC10103567
DOI
10.1093/europace/euac159
PII: 6700663
Knihovny.cz E-zdroje
- Klíčová slova
- AV delay optimization, Body surface potential mapping, Cardiac resynchronization therapy, ECG imaging, Heart failure, LV lead positioning,
- MeSH
- elektrokardiografie MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- prostředky srdeční resynchronizační terapie MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- srdeční arytmie terapie MeSH
- srdeční resynchronizační terapie * metody MeSH
- srdeční selhání * diagnóza terapie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: The standard deviation of activation time (SDAT) derived from body surface maps (BSMs) has been proposed as an optimal measure of electrical dyssynchrony in patients with cardiac resynchronization therapy (CRT). The goal of this study was two-fold: (i) to compare the values of SDAT in individual CRT patients with reconstructed myocardial metrics of depolarization heterogeneity using an inverse solution algorithm and (ii) to compare SDAT calculated from 96-lead BSM with a clinically easily applicable 12-lead electrocardiogram (ECG). METHODS AND RESULTS: Cardiac resynchronization therapy patients with sinus rhythm and left bundle branch block at baseline (n = 19, 58% males, age 60 ± 11 years, New York Heart Association Classes II and III, QRS 167 ± 16) were studied using a 96-lead BSM. The activation time (AT) was automatically detected for each ECG lead, and SDAT was calculated using either 96 leads or standard 12 leads. Standard deviation of activation time was assessed in sinus rhythm and during six different pacing modes, including atrial pacing, sequential left or right ventricular, and biventricular pacing. Changes in SDAT calculated both from BSM and from 12-lead ECG corresponded to changes in reconstructed myocardial ATs. A high degree of reliability was found between SDAT values obtained from 12-lead ECG and BSM for different pacing modes, and the intraclass correlation coefficient varied between 0.78 and 0.96 (P < 0.001). CONCLUSION: Standard deviation of activation time measurement from BSM correlated with reconstructed myocardial ATs, supporting its utility in the assessment of electrical dyssynchrony in CRT. Importantly, 12-lead ECG provided similar information as BSM. Further prospective studies are necessary to verify the clinical utility of SDAT from 12-lead ECG in larger patient cohorts, including those with ischaemic cardiomyopathy.
Zobrazit více v PubMed
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JPet al. . Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329–38. PubMed
Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly Set al. . Resynchronization-defibrillation for ambulatory heart failure trial investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385–95. PubMed
Gold MR, Thebault C, Linde C, Abraham WT, Gerritse B, Ghio Set al. . Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the resynchronization reverses remodeling in systolic left ventricular dysfunction (REVERSE) study. Circulation 2012;126:822–9. PubMed
Sedova K, Repin K, Donin G, Van Dam P, Kautzner J. Clinical utility of body surface potential mapping in CRT patients. Arrhythm Electrophysiol Rev 2021;10:113–9. PubMed PMC
Johnson WB, Vatterott PJ, Peterson MA, Bagwe S, Underwood RD, Bank AJet al. . Body surface mapping using an ECG belt to characterize electrical heterogeneity for different left ventricular pacing sites during cardiac resynchronization: relationship with acute hemodynamic improvement. Heart Rhythm 2017;14:385–91. PubMed
Bank AJ, Gage RM, Curtin AE, Burns KV, Gillberg JM, Ghosh S. Body surface activation mapping of electrical dyssynchrony in cardiac resynchronization therapy patients: potential for optimization. J Electrocardiol 2018;51:534–41. PubMed
Elliott MK, Blauer J, Mehta VS, Sidhu BS, Gould J, Jackson Tet al. . Comparison of electrical dyssynchrony parameters between electrocardiographic imaging and a simulated ECG belt. J Electrocardiol 2021;68:117–23. PubMed
Rosík V, Karas S, Hebláková E, Tyšler M, Filipová S. Portable device for high resolution ECG mapping. Meas Sci Rev 2007;7:4.
Pan J, Tompkins WJ. A real-time QRS detection algorithm. IEEE Trans Biomed Eng 1985;32:230–6. PubMed
Marinucci D, Sbrollini A, Marcantoni I, Morettini M, Swenne CA, Burattini L. Artificial neural network for atrial fibrillation identification in portable devices. Sensors (Switzerland) 2020;20:1–16. PubMed PMC
Boonstra MJ, Roudijk RW, Brummel R, Kassenberg W, Blom LJ, Oostendorp TFet al. . Modeling the His-Purkinje effect in non-invasive estimation of endocardial and epicardial ventricular activation. Ann Biomed Eng 2022;50:343–59. PubMed PMC
Gage RM, Curtin AE, Burns KV, Ghosh S, Gillberg JM, Bank AJ. Changes in electrical dyssynchrony by body surface mapping predict left ventricular remodeling in patients with cardiac resynchronization therapy. Heart Rhythm 2017;14:392–9. PubMed
Rickard J, Jackson K, Biffi M, Vernooy K, Bank A, Cerkvenik Jet al. . The ECG belt for CRT response trial: design and clinical protocol. Pacing Clin Electrophysiol 2020;43:1063–71. PubMed
Gage RM, Khan AH, Syed IS, Bajpai A, Burns KV, Curtin AEet al. . Twelve-lead ECG optimization of cardiac resynchronization therapy in patients with and without delayed enhancement on cardiac magnetic resonance imaging. J Am Heart Assoc 2018;7:e009559. PubMed PMC